New submitter rex.clts writes "In the IT security world, it is common practice to withhold specifics when announcing a newly discovered software vulnerability. The exact details regarding a buffer overflow or race condition are typically kept secret until a patch is available, to slow the proliferation of exploits against the hole. For the first time, this practice has been extended to medical publishing. A new form of Botulism has been identified, but its DNA sequence (the genetic code that makes up the toxin) has been withheld, until an antidote has been found. It seems that censorship in the name of "security" is spreading (with DHS involved this comes as no surprise.) Is this the right move?"